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Severe infections due to Staphylococcus aureus require prolonged therapy for cure, and relapse may occur even
years after the first episode. Persistence of S. aureus may be explained, in part, by nasal carriage of S. aureus,
which occurs in a large percentage of healthy humans and represents a major source of systemic infection.
However, the persistence of internalized S. aureus within mucosal cells has not been evaluated in humans. Here,
we provide the first in vivo evidence of intracellular reservoirs of S. aureus in humans, which were assessed in
endonasal mucosa specimens from patients suffering from recurrent S. aureus rhinosinusitis due to unique,
patient-specific bacterial clonotypes. Heavily infected foci of intracellular bacteria located in nasal epithelium,
glandular, and myofibroblastic cells were revealed by inverted confocal laser scan fluorescence and electron
microscopic examination of posttherapy intranasal biopsy specimens from symptom-free patients undergoing
surgery on the sinuses. Intracellular residence may provide a sanctuary for pathogenic bacteria by protecting
them from host defense mechanisms and antibiotic treatment during acute, recurrent S. aureus rhinosinusitis.
Staphylococcus aureus is a major pathogen that has a
high potential for colonizing anterior nares or other
body sites of both infected patients and healthy carriers
[1–3]. Colonized patients are a predominant source of
S. aureus in hospitals, and a substantial proportion of
hospitalized patients develop severe S. aureus infections
from their own endogenous nasal reservoirs [2–5]. Con-
flicting observations exist on the molecular mechanisms
of S. aureus nasal colonization, which have been studied
mostly in chronic carriers. Binding properties of S. aureus
cell-surface components (e.g., cell-wall components such
as teichoic acids) [2, 6] or cell wall–associated proteins,
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known as “microbial surface components recognizing
adhesive matrix molecules” [7, 8], with either carbohy-
drate-rich surface components of mucosal epithelial cells
[2] or nasal mucus secretions [9], were extensively stud-
ied. Although it provides suitable explanation for initial
binding and short-term carriage, extracellular binding of
colonizing bacteria can hardly explain the long-term car-
riage of clonally identical strains of S. aureus, such as
those found in a significant percentage of healthy carriers
[4, 10–13]. Indeed, the presence of effective local defense
mechanisms, such as the retrograde mucociliary trans-
port, or locally secreted antimicrobial peptides [14, 15]
should, in principle, lead to rapid elimination or re-
placement of colonizing organisms by exogenous strains
[12, 16] and, thus, prevent long-term nasal carriage of
identical strains.
Another mechanism that may potentially contribute
to long-term endonasal persistence of S. aureus in some
patients is the possibility of intracellular survival in a
range of cell types frequently referred to as “nonpro-
fessional phagocytes” [17, 18]. Notwithstanding its
status as an extracellular pathogen [1], S. aureus reveals
a considerable potential for in vitro invasion of epi-
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Figure 1. Clinical course for 3 patients during a 3-year period (left panel). The occurrence of symptomatic episodes, either treated with systemic
antibiotics or untreated, is indicated by green or red triangles, respectively. Black arrows indicate surgical biopsy specimens, and boxes represent
Staphylococcus aureus–positive cultures. The nos. in boxes refer to strain isolates tested by pulsed-field gel electrophoresis (PFGE) (right panel).
thelial and endothelial cells, osteoblasts, fibroblasts, and human
embryonic kidney cell lines [18–28]. Several studies have dem-
onstrated that fibronectin-binding proteins promote S. aureus
internalization by binding to circulating or cellular fibronectin,
which, in turn, acts as a molecular bridge to the host cell fibro-
nectin receptor integrin a5b1 [17–21, 23, 24, 26–29]. Integrin-
mediated invasion of S. aureus into nonprofessional phagocytes
is promoted by activation of Src family protein-tyrosine kinases
[25, 28]. These in vitro data suggest that intracellular reservoirs
might provide a sanctuary for S. aureus by protecting them from
extracellular host defense mechanisms and from the most com-
monly used antibiotics, such as b-lactams, which do not penetrate
into cells [17, 18]. However, evidence of such intracellular res-
ervoirs and their in vivo contribution to persistence of S. aureus
in humans is still lacking. The objective of the present study is
to provide morphological evidence of intracellular foci of S. au-
reus, which may act as potential reservoirs for the multiple re-
current episodes of rhinosinusitis caused by unique, patient-spe-
cific clonotypes of this pathogen.
PATIENTS, MATERIALS, AND METHODS
Patients. This study was performed in compliance with the
ethical guidelines established by the University Hospitals of
Geneva. From January 2000 to December 2001, 750 outpatients
were treated for persistent rhinosinusitis in the rhinology unit
of our institution by endoscopic examination of the nasal cav-
ities. The presence of polyps, crust, and/or purulent secretions
in the middle meatus was observed in 135 patients (18%), of
whom 39 also yielded S. aureus–positive cultures on samples
from their middle meatus, conducted by endoscopy. Three of
these patients required more-extensive investigations because
they experienced multiple rhinosinusitis episodes during a 3-
year period (range, 12–18 episodes) and regularly relapsed with
acute symptoms of nasal obstruction, anterior and posterior
rhinorhea, and headache within 2–3 months after standard
systemic antimicrobial therapy and daily topical administration
of nasal steroids (400 mg of mometasoni-17furoas) [30]. During
each acute episode, patients’ nasal mucosa, which was evaluated
by endoscopic examination of the middle meatus, displayed an
erythematous and edematous epithelium and the presence of
polyps with purulent secretions (patients 1 and 3). The diag-
nosis of rhinosinusitis was established by direct coronal com-
puted tomographic scanning, which showed inflammatory mu-
cosa thickening 5 mm in 12 paranasal sinuses [31]. Direct
endoscopically guided sampling of patients’ middle meatus re-
vealed the recurrent presence (during consecutive rhinosinusi-
tis episodes) of S. aureus but not of other upper respiratory
pathogens, such as Streptoccoccus pneumoniae and Haemophilus
influenzae. Patients yielding S. aureus–positive cultures in the
middle meatus were treated by standard regimens of oral an-
tistaphylococcal antibiotics, in accordance with the in vitro sen-
sitivity data (none of the S. aureus isolates displayed resistance
to methicillin), combined with topical administration of nasal
steroids (400 mg of mometasoni-17furoas), as recommended
elsewhere [30]. At 2 weeks after completion of treatment, the
overall therapeutic response of each patient was assessed for
relief of symptoms, reduction in size of polyps, and disap-
pearance of crusts and/or purulent discharge, as evaluated by
endoscopic examination of the nasal cavities.
Endoscopic nasal surgery—including partial middle turbinec-
tomy, middle meatotomy, and anterior ethmoidectomy—was
performed with the patients under general anesthesia. Tissue
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Figure 2. Histological location and immunohistochemical detection of Staphylococcus aureus (center). Lateral view of the nasal wall, showing (1)
anterior nares, (2) inferior turbinate, (3) anterior part of the middle turbinate (where surgical biopsy specimens were obtained) (red), (4) middle turbinate,
and (5) rhinopharynx. A and B, Standard histological views of dermal epithelium (arrow) and mucosal glands (star). Sections were stained with
hematoxylin-eosin (A). Mucosal glands are surrounded by fibrotic tissue visualized by blue-stained collagen deposition (B) on Masson-trichrome–stained
sections. Bar, 20 mm. C–E, Intracellular localization of S. aureus in various cell types, by confocal microscopy. S. aureus were labeled with specific
antibody (green), and cell nuclei were labeled with TOTO-III (blue). Epithelial cells were visualized with anti-keratin (red; C), myofibroblasts were
visualized with anti–a–smooth muscle actin (D), and inflammatory cells were visualized with anti-CD45 (red; E) antibodies. In the top images of each
panel, projections were constructed from confocal Z stacks (0.5 mm thick). The bottom images are vertical views in the Z-plane and were obtained
by combining the series of X–Y scans taken along the Z-axis. Lines drawn in the top images indicate where the Z-sections were generated.
specimens obtained during the surgical procedure were evaluated
by routine anatomic, pathological, and histological procedures
and were screened for the presence of microbial pathogens.
Bacteriological identification and molecular typing. Swabs
of nasal secretions or biopsy specimens (disrupted in a sterile
tissue grinder in 500 mL of 0.9% NaCl) were plated on blood,
chocolate, and Columbia colistin nalidixic agar (Becton Dick-
inson), and then S. aureus was identified according to standard
bacteriological criteria. Molecular typing of sequential S. au-
reus isolates was performed by pulsed-field gel electrophoresis
(PFGE) of chromosomal DNA digested with SmaI (Bio-Rad),
by use of a CHEF MAPPER system (Bio-Rad) [32]. DNA band-
ing patterns of the different gels were analyzed by use of the
software GelCompar (version 4.1; Applied Math) and inter-
preted according to criteria published elsewhere [32].
Indirect immunofluorescence, confocal laser scanning mi-
croscopy, and light microscopy. Nasal biopsy specimens were
embedded in OCT 4583 (Miles Scientific) and frozen in pre-
cooled liquid isopentane. Three-micrometer cryostat sections
were fixed in acetone for 5 min at20C and stained with anti–
S. aureus antibodies (mouse IgM; Chemicon International) com-
bined with antibodies directed against either human keratin
(wide-spectrum screen rabbit polyclonal antibody [Dako]) ora–
smooth muscle actin mouse IgG2a [33] or human CD45 (mouse
IgG1 [BD Biosciences PharMingen]). Control experiments as-
sessed the specificity of anti–S. aureus antibodies directed against
staphylococcal peptidoglycan, which, under the conditions used
for immunofluorescence, did not cross-react with Staphylococcus
epidermidis or other gram-positive species. Subsequently, sam-
ples were incubated with Alexa 488–labeled anti-mouse IgM an-
tibodies (Molecular Probes) and with secondary tetramethylrho-
damine isothiocyanate–conjugated antibodies recognizing either
rabbit (Jackson ImmunoResearch Labs) or the different mouse
isotypes (Southern Biotechnology Associates); the secondary an-
tibodies were diluted in PBS solution containing 1:100 human
serum and 1:1000 nuclear dye (TOTO-III; Molecular Probes)
and were mounted in polyvinyl alcohol mounting medium. An
inverted confocal laser scan fluorescence microscope (Carl Zeiss)
was used to collect 3-D image sets. Stacks of confocal images
were processed by use of IMARIS software (version 3.2; Bit-
plane AG) for 3-D view of the infected cells. Simultaneous de-
tection, by confocal imaging, of immunostained S. aureus and
cytoplasmic components (e.g., cytokeratin) on 0.5-mm-thick
cross-sectional images was performed to assess the intracyto-
plasmic localization of bacteria.
For light microscopic examination, pieces of tissue were fixed
in 10% neutral buffered formol and embedded in paraffin. Four-
micrometer serial sections were stained with either hematoxylin-
eosin or blue alanine Masson’s trichrome or were immunostained
with anti–S. aureus antibodies. Immunoperoxidase staining was
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Figure 3. Presence of Staphylococcus aureus in epithelial cells of nasal epithelium, evaluated by transmission electron microscopy (TEM) (arrows;
B), immunohistochemical methods (brown; C), and immununofluorescence (S. aureus in green, keratin in red, and nuclei in blue; D). A, Schematic
representation of the multistep protocol used to optimize the detection of S. aureus by TEM. The highly infected areas (star corresponding to the
dashed circle in C) were selected by microscopy (step 1), and fragments were punched from the paraffin-embedded block (step 2) and processed for
TEM. Insets in B and C represent a zoomed portion of each image. ci, cilia from the cell apical surface; ep, epithelial cell; N, nucleus; pm, plasma
membrane. Bars in C and D, 20 mm. Original magnification in B, 2200; original magnification in inset, 23,000.
performed as described elsewhere [34]. Sections were examined
by use of an Axiophot photomicroscope (Carl Zeiss), and images
were acquired by use of an Axiocam camera (Carl Zeiss).
Transmission electron microscopy (TEM). Highly infected
areas were selected by microscopic examination of paraffin-em-
bedded tissues stained, by immunochemical methods, with anti–
S. aureus antibodies, as described above, and punch fragments
of the paraffin-embedded block were then deparaffined in xylol
and ethanol, followed by fixation in 1% osmium tetroxide for 1
h and subsequent dehydration and embedding in Epon. Thin
sections were stained with uranyl acetate and lead citrate and
examined by use of a CM10 electron microscope (Philips).
RESULTS
The time course of multiple symptomatic rhinosinusitis epi-
sodes (range during a 3-year period, 12–18) for each of the 3
patients is shown in parallel with S. aureus–positive cultures of
middle meatus samples and courses of systemic antimicrobial
therapy combined with daily topical administration of nasal
steroids (figure 1). PFGE data were used to assess the presence
of single, patient-specific clonotypes of S. aureus during mul-
tiple rhinosinusitis episodes (figure 1).
Histological analysis of posttherapy intranasal biopsy spec-
imens from patients with S. aureus rhinosinusitis undergoing
surgery on the sinuses showed the presence of diffuse fibrotic
areas surrounding mucous-producing glands (figure 2B) that
were characterized by expression of a-smooth muscle actin
(data not shown), an actin isoform typical of myofibroblastic
cells, which are abundant and persistent in fibrotic inflam-
matory tissue [35]. Although the presence of S. aureus was
easily detected by microbiological cultures of biopsy specimens,
its detection by use of a cell wall–specific monoclonal antibody
was far more difficult, because of highly irregular spatial dis-
tribution. Intracellular location of S. aureus was assessed by
confocal immunofluorescence microscopic examination of na-
sal specimens that combined immunodetection of S. aureus
with specific markers of different cell types. S. aureus frequent-
ly colocalized with cytokeratin (intracytoplasmic epithelia–spe-
cific intermediate filament protein) [36] in mucous glands (fig-
ure 2C) and nasal epithelial cells (figure 3D). By use of Z-scan,
S. aureus clusters were also observed in myofibroblastic cells at
the same level as was a-smooth muscle actin, which appeared
to form a constricting ring around bacteria (figure 2D). As
expected, intracellular S. aureus were also identified in CD45-
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positive professional phagocytic cells distributed throughout
the connective tissue, in epithelium, or in fibrotic areas (figure
2E). Confocal microscopic analyses provided further evidence
that approximately one-third of the S. aureus–infected cells,
regardless of the cell type, carried 110 bacteria.
Intracellular S. aureus were also seen by TEM examination of
highly infected foci (selected by microscopic examination of tis-
sue sections stained, by immunochemical methods, with anti–S.
aureus) (figure 3C) that had been punched from paraffin-em-
bedded tissue and reprocessed for TEM (figure 3A). This protocol
was required for accurate localization of S. aureus–containing
areas that were dispersed within nasal mucosa specimens. TEM
examination (figure 3B) confirmed the presence of numerous
intracytoplasmic S. aureus in nasal epithelial cells.
DISCUSSION
The mechanisms of persistence and recurrence of S. aureus in
humans are still partly speculative. The lack of in vivo mor-
phological evidence of intracellular S. aureus reservoirs, which
may contribute to clinically important S. aureus–persistent dis-
eases, might be explained, in part, by technical difficulties in
localizing the highly focalized S. aureus intracellular reservoirs
[17]. Despite its in vitro potential for invading a range of non-
professional phagocytes [18–28], S. aureus has no dedicated
molecular system of penetration, in contrast to enteroinvasive
bacteria [37].
The fate of internalized S. aureus after endocytosis in cell-
culture models may be determined by the interplay between host
cell defense mechanisms and the intrinsic virulence of internal-
ized S. aureus strains. A frequently described scenario is that of
initial intraphagosomal survival, followed by S. aureus escape into
the cytoplasm, followed by intracellular replication and eventually
leading to host cell apoptosis [18, 38–44]. However, in vitro
studies showing rapid (within 24–48 h) triggering of apoptosis
by intracellular S. aureus are of uncertain relevance for explaining
long-term persistence of bacteria in vivo. In this context, an
important determinant shown to significantly improve S. aureus
intracellular survival is the emergence or selection by the intra-
cellular milieu of small colony variants (SCVs) displaying a de-
creased growth rate and diminished hemolytic activity [45, 46].
Several observations suggest that, by alteration of their metabolic
properties and reduction of their virulence, SCVs may have in-
creased intracellular survival as a result of prevention of or sub-
stantially delayed host cell lysis or apoptosis [45, 46]. Further-
more, SCVs also have been shown to have decreased susceptibility
to some bactericidal antibiotics [47].
Demonstration of highly focalized intracellular reservoirs of
S. aureus in various cell types of the endonasal mucosa from
patients facing multiple episodes of recurrent rhinosinusitis
represents an important step toward a more complete under-
standing of persistent infection. This observation raises sever-
al questions: (1) What are the risk factors contributing to the
emergence of intracellular reservoirs of S. aureus? (2) If the
intracellular residence of S. aureus indeed provides a sanctuary
for the bacteria by protecting them from host defense mech-
anisms and commonly used antibiotic treatments, therefore
explaining persistence and recurrence of S. aureus in these pa-
tients, how should antimicrobial therapy be optimized? (3)
Does intracellular infection play a role in other severe S. aureus
infections, such as endocarditis or osteomyelitis? (4) How can
our study contribute to understanding of S. aureus colonization
in asymptomatic patients, which is an extremely frequent event,
affecting ∼20%–30% of healthy individuals? Although patients
with recurrent and severe S. aureus rhinosinusitis are more
suitable for morphological studies—because they should have
locally higher bacterial densities, compared with healthy car-
riers—several characteristics of S. aureus colonization look sim-
ilar in both groups, such as recurrence or persistence of the
same S. aureus clonotype for prolonged periods, even after at-
tempts of decolonization with topical or systemic agents. This
finding, however, remains speculative, and further studies are
being undertaken to address these questions.
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